期刊文献+
共找到2,616篇文章
< 1 2 131 >
每页显示 20 50 100
Reproducibility of perfusion CT derived CBV and rCBV measurements with different slice thickness in patients with brain neoplasms
1
作者 Liqing Kang Hongyuan Zhang +3 位作者 Yuefeng Chen Zhaowei Song Yanfeng Xu Yanxu Che 《The Chinese-German Journal of Clinical Oncology》 CAS 2008年第2期98-102,共5页
Objective:To assess inter-and intraobserver reproducibility for measuring perfusion CT derived cerebral blood volume (CBV) and relative cerebral blood volume (rCBV) with different slice thickness in patients with brai... Objective:To assess inter-and intraobserver reproducibility for measuring perfusion CT derived cerebral blood volume (CBV) and relative cerebral blood volume (rCBV) with different slice thickness in patients with brain neoplasms. Meth- ods: Three independent observers who were blinded to the histopathologic diagnosis performed perfusion derived CBV and rCBV measurements with 5 mm and 10 mm slice thickness in 52 patients with various cerebral neoplasms. The results of the measurements with different slice thickness were compared. Calculation of coefficient of variation (CV), and relative paired difference of the measurements were used to determine the levels of inter- and intraobserver reproducibility. Results: The differences of CBV and rCBV measurements between different slice thickness groups were statistically significant (P < 0.05) respectively in observer 2, and were not significant in the other two observers (P > 0.05). For the same slice thickness, both the difference of CBV and rCBV measurements among the three observers were not statistically significant. Interobserver CV and relative paired difference of the measurements with 10 mm slice thickness group were slightly lower than those of 5 mm slice thickness group. Interobserver CV and relative paired difference of CBV group were slightly lower than those of rCBV group. The intraobserver differences of CBV and rCBV in 10 mm slice thickness group were statistically significant for observer 2 respectively. No other intraobserver differences of measurements were statistically significant. CV and relative paired difference of intraobserver CBV and rCBV measurements for observer 2 were significantly higher than for the other two observers. Conclusion: High reproducibility of CBV and rCBV measurements was acquired with the two different slice thickness. Suitable training may be helpful to maintain a high level of consistency for measurements. 展开更多
关键词 brain neoplasm PERFUSION computed tomography reproducibility of results
下载PDF
RAS野生型转移性结直肠癌抗表皮生长因子受体单抗维持治疗中国专家共识(2024版)
2
作者 中国临床肿瘤学会结直肠癌专家委员会 徐瑞华 张东生 《消化肿瘤杂志(电子版)》 2024年第3期261-271,共11页
对于接受标准一线治疗达到疾病控制的转移性结直肠癌(mCRC),后续治疗策略的制订应在维持疗效的同时注重改善患者生活质量。化疗联合抗表皮生长因子受体(EGFR)单抗是RAS野生型mCRC患者的标准一线治疗方案。当一线含抗EGFR单抗诱导治疗达... 对于接受标准一线治疗达到疾病控制的转移性结直肠癌(mCRC),后续治疗策略的制订应在维持疗效的同时注重改善患者生活质量。化疗联合抗表皮生长因子受体(EGFR)单抗是RAS野生型mCRC患者的标准一线治疗方案。当一线含抗EGFR单抗诱导治疗达到最佳疗效、且处于疾病缓解或稳定状态时,含抗EGFR单抗维持治疗方案可在维持疗效获益的同时,降低毒副反应和提高患者生活质量。本共识基于循证医学和临床实践,进一步明确抗EGFR单抗维持治疗的应用时机、方案选择、不良反应管理和后续策略选择,为抗EGFR单抗维持治疗提供临床应用规范化标准和指导,以期使患者的治疗最大化获益。 展开更多
关键词 结直肠肿瘤 转移性 raS野生型 抗EGFR单抗 维持治疗
下载PDF
微RNA-196a-1-3p靶向Ras响应元件结合蛋白调控胆管癌细胞增殖的机制研究 被引量:1
3
作者 丁敬健 张升涛 +3 位作者 郭永锋 王尚毓 罗孔亮 董伟 《安徽医药》 CAS 2024年第7期1399-1403,I0004,共6页
目的探讨转化生长因子β(TGF-β)调控人胆管癌细胞系RBE细胞增殖的关键微RNA(miRNA)及其潜在的机制。方法该研究起止时间为2020年1月至2022年1月。磷酸盐缓冲液(PBS)处理为对照组,TGF-β处理为TGF-β组,TGF-β抗体处理为抗体组。检测三... 目的探讨转化生长因子β(TGF-β)调控人胆管癌细胞系RBE细胞增殖的关键微RNA(miRNA)及其潜在的机制。方法该研究起止时间为2020年1月至2022年1月。磷酸盐缓冲液(PBS)处理为对照组,TGF-β处理为TGF-β组,TGF-β抗体处理为抗体组。检测三组RBE细胞的增殖水平。miRNA高通量测序检测三组RBE细胞的miRNA调控变化,并进行miRNA模拟物过表达筛选鉴定受TGF-β调控的影响RBE细胞增殖水平的关键miRNA。miRNA数据库(miRDB)在线分析miRNA的潜在底物,并通过小干扰RNA(siRNA)敲低筛选鉴定影响RBE细胞增殖水平的关键底物。结果相比于对照组,TGF-β组RBE细胞的增殖水平上升(1.62±0.07比2.35±0.09,P<0.05),抗体组RBE细胞的增殖水平下降(1.62±0.07比1.11±0.08,P<0.05)。过表达微RNA-196a-1-3p(miR-196a-1-3p)时,RBE细胞的增殖水平下降(P<0.05)。敲低Ras响应元件结合蛋白(RREB1)时,RBE细胞的增殖水平下降(P<0.05)。过表达miR-196a-1-3p后,RBE细胞中RREB1的信使RNA(mRNA)和蛋白水平下降(P<0.05)。敲低miR-196a-1-3p后,RBE细胞中RREB1与SMAD家族蛋白3(SMAD3)的相互作用增加。敲低SMAD3后,RBE细胞的增殖水平下降(P<0.05)。与仅敲低SMAD3相比,敲低SMAD3的同时过表达RREB1的RBE细胞的增殖水平无显著变化,并且同时敲低SMAD3和miR-196a-1-3p的RBE细胞的增殖水平无显著变化。结论TGF-β能够通过miR-196a-1-3p/RREB1/SMAD3轴促进RBE细胞增殖;miR-196a-1-3p和RREB1可作为潜在的治疗胆管癌的靶标,为针对该靶标的新药研发奠定了基础。 展开更多
关键词 胆管肿瘤 转化生长因子β 细胞增殖 微RNA-196a-1-3p ras反应元件结合蛋白1 SMAD家族成员3
下载PDF
程序性死亡因子受体-1抑制剂联合化疗和贝伐珠单抗一线治疗RAS突变MSS型晚期结直肠癌的疗效观察
4
作者 孙子娟 汪海岩 +1 位作者 施慧婕 司悦 《安徽医药》 CAS 2024年第9期1850-1855,共6页
目的评估程序性死亡因子受体-1(PD-1)抑制剂联合化疗和贝伐珠单抗一线治疗大鼠肉瘤病毒(RAS)基因突变、微卫星稳定(MSS)型晚期结直肠癌病人的疗效及安全性。方法2021年6月至2022年6月徐州医科大学附属医院收治的67例RAS基因突变MSS型晚... 目的评估程序性死亡因子受体-1(PD-1)抑制剂联合化疗和贝伐珠单抗一线治疗大鼠肉瘤病毒(RAS)基因突变、微卫星稳定(MSS)型晚期结直肠癌病人的疗效及安全性。方法2021年6月至2022年6月徐州医科大学附属医院收治的67例RAS基因突变MSS型晚期结直肠癌病人分为两组,观察组(n=32)行PD-1抑制剂联合化疗和贝伐珠单抗,对照组(n=35)行化疗联合贝伐珠单抗,观察两组的治疗效果及不良反应。结果观察组和对照组的客观缓解率(ORR)分别为78.1%和51.4%(P<0.05),疾病控制率(DCR)分别为96.9%和77.1%(P<0.05);观察组中位无进展生存期(mPFS)较对照组延长,分别为12.9个月和11.2个月,差异有统计学意义(P<0.05)。观察组的不良反应率高于对照组(90.6%比88.6%),差异无统计学意义(P>0.05),但均可控制,且未发生致死性事件。结论PD-1抑制剂联合化疗和贝伐珠单抗一线治疗RAS基因突变MSS型晚期结直肠癌初步显示疗效显著,此类病人在常规贝伐珠单抗联合化疗的基础上可以考虑加用PD-1抑制剂。 展开更多
关键词 结直肠肿瘤 微卫星稳定 大鼠肉瘤病毒基因突变 程序性死亡因子受体-1抑制剂 贝伐珠单抗 卡瑞利珠/信迪利
下载PDF
Hp、RASAL2、CDH1及TP53对胃癌前病变与早期胃癌的鉴别诊断价值
5
作者 马越 陈伟 +2 位作者 刘宝英 付丹丹 周彤 《临床误诊误治》 CAS 2024年第11期39-45,共7页
目的探讨幽门螺杆菌(Hp)、RAS蛋白激活样因子2(RASAL2)、钙黏蛋白1(CDH1)及肿瘤抑制基因P53(TP53)对胃癌前病变与早期胃癌的鉴别诊断价值。方法选取2021年6月至2023年6月收治的早期胃癌52例,根据1:1选例原则另选取同期胃癌前病变52例、... 目的探讨幽门螺杆菌(Hp)、RAS蛋白激活样因子2(RASAL2)、钙黏蛋白1(CDH1)及肿瘤抑制基因P53(TP53)对胃癌前病变与早期胃癌的鉴别诊断价值。方法选取2021年6月至2023年6月收治的早期胃癌52例,根据1:1选例原则另选取同期胃癌前病变52例、胃炎52例,分别纳入胃癌组、癌前组、胃炎组。比较3组及不同病理特征的早期胃癌患者Hp、RASAL2、CDH1、TP53阳性表达率,比较胃癌组Hp阳性、阴性患者RASAL2、CDH1、TP53阳性表达率,采用Spearman相关分析探讨各指标阳性表达与早期胃癌患者部分病理特征的相关性,采用受试者工作特征(ROC)曲线分析联合检测对早期胃癌及胃癌前病变的鉴别诊断价值。结果3组Hp、CDH1、TP53阳性表达率胃癌组>癌前组>胃炎组,RASAL2阳性表达率胃癌组<癌前组<胃炎组,差异有统计学意义(P<0.05,P<0.01)。胃癌组Hp阳性患者CDH1、TP53阳性表达率高于Hp阴性患者,RASAL2阳性表达率低于Hp阴性患者(P<0.05,P<0.01);早期胃癌患者Hp、RASAL2、CDH1、TP53阳性表达率在肿瘤浸润深度及淋巴结转移方面比较差异有统计学意义(P<0.05,P<0.01)。Hp、CDH1、TP53阳性表达与早期胃癌肿瘤浸润深度、淋巴结转移均呈正相关,RASAL2阳性表达与之呈负相关(P<0.01)。ROC曲线分析结果显示,Hp、RASAL2、CDH1、TP53联合诊断胃癌前病变的曲线下面积(AUC)为0.904(95%CI:0.846,0.945),联合诊断早期胃癌的AUC为0.894(95%CI:0.819,0.946)。结论Hp、CDH1、TP53在早期胃癌组织中阳性表达率较高,RASAL2阳性表达率较低,联合检测对胃癌前病变及早期胃癌具有一定鉴别诊断价值,可作为临床鉴别诊断胃癌前病变、早期胃癌的辅助指标。 展开更多
关键词 胃肿瘤 癌前病变 胃炎 幽门螺杆菌 raS蛋白激活样因子2 钙黏蛋白1 肿瘤抑制基因P53 诊断价值
下载PDF
Relationship between HER-2 overexpression and brain metastasis in esophageal cancer patients 被引量:5
6
作者 Taher Abu Hejleh Barry R DeYoung +9 位作者 Eric Engelman Jeremy M Deutsch Bridget Zimmerman Thorvardur R Halfdanarson Daniel J Berg Kalpaj R Parekh William R Lynch Mark D Iannettoni Sudershan Bhatia Gerald Clamon 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2012年第5期103-108,共6页
AIM:To study if HER-2 overexpression by locally advanced esophageal cancers increase the chance of brain metastasis following esophagectomy.METHODS:We retrospectively reviewed the medical records of esophageal cancer ... AIM:To study if HER-2 overexpression by locally advanced esophageal cancers increase the chance of brain metastasis following esophagectomy.METHODS:We retrospectively reviewed the medical records of esophageal cancer patients who underwent esophagectomy at University of Iowa Hospitals and Clinics between 2000 and 2010.Data analyzed consisted of demographic and clinical variables.The brain metastasis tissue was assayed for HER-2 overexpression utilizing the FDA approved DAKO Hercept Test.RESULTS:One hundred and forty two patients were reviewed.Median age was 64 years(36-86 years).Eighty eight patients(62%) received neoadjuvant chemoradiotherapy.Pathological complete and partial responses were achieved in 17(19%) and 71(81%) patients.Cancer relapsed in 43/142(30%) patients.The brain was the first site of relapse in 9/43 patients(21%,95% CI:10%-36%).HER-2 immunohistochemistry testing of the brain metastasis tissue showed that 5/9(56%) cases overexpressed HER-2(3+ staining).CONCLUSION:HER-2 overexpression might be associated with increased risk of brain metastasis in esophageal cancer patients following esophagectomy.Further studies will be required to validate this observation. 展开更多
关键词 ESOPHAGEAL neoplasm ESOPHAGEAL cancer HER-2 Genes erbB-2 brain neoplasms brain metastasis
下载PDF
Patients with brain metastases from gastrointestinal tract cancer treated with whole brain radiation therapy:Prognostic factors and survival 被引量:10
7
作者 SusanneBartelt FelixMomm ChristianWeissenberger JohannesLutterbach 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第22期3345-3348,共4页
AIM: To identify the prognostic factors with regard to survival for patients with brain metastasis from primary tumors of the gastrointestinal tract. METHODS: Nine hundred and sixteen patients with brain metastases, t... AIM: To identify the prognostic factors with regard to survival for patients with brain metastasis from primary tumors of the gastrointestinal tract. METHODS: Nine hundred and sixteen patients with brain metastases, treated with whole brain radiation therapy (WBRT) between January 1985 and December 2000 at the Department of Radiation Oncology, University Hospital Freiburg, were analyzed retrospectively. RESULTS: Fifty-seven patients presented with a primary tumor of the gastrointestinal tract (esophagus: n=0, stomach: n=10, colorectal: n=47). Twenty-six patients had a solitary brain metastasis, 31 patients presented with multiple brain metastases. Surgical resection was performed in 25 patients. WBRT was applied with daily fractions of 2 Gray (Gy) or 3Gy to a total dose of 50Gy or 30Gy, respectively. The interval between diagnoses of the primary tumors and brain metastases was 22.6mo vs 8.0mo for patients with primary tumors of the colon/rectum vs other primary tumors, respectively (P<0.01, log-rank). Median overall survival for all patients with brain metastases (n=916) was 3.4mo and 3.2mo for patients with gastrointestinal neoplasms. Patients with gastrointestinal primary tumors presented significantly more often with a solitary brain metastasis than patients with other primary tumors (P<0.05, log-rank). In patients with gastrointestinal neoplasms (n=57), the median overall survival was 5.8 mo for patients with solitary brain metastasis vs 2.7mo for patients with multiple brain metastases (P<0.01, log-rank). The median overall survival for patients with a Karnofsky performance status (KPS) ≥70 was 5.5mo vs 2.1mo for patients with KPS <70 (P<0.01, log-rank). At multivariate analysis (Cox Model) the performance status and the number of brain metastases were identified as independent prognostic factors for overall survival. CONCLUSION: Brain metastases occur late in the course of gastrointestinal tumors. Pretherapeutic variables like KPS and the number of brain metastases have a profound influence on treatment outcome. 展开更多
关键词 ADULT Aged Aged 80 and over brain neoplasms FEMALE Gastrointestinal neoplasms Humans MALE Middle Aged Prognosis Retrospective Studies Risk Factors Survival Analysis
下载PDF
Brain metastasis of hepatocellular carcinoma:A case report and review of the literature 被引量:4
8
作者 Bilge Tunc Levent Filik +1 位作者 Irsel Tezer-Filik Burhan Sahin 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第11期1688-1689,共2页
Hepatocellular carcinoma (HCC) is one of the most frequent malignancies in the world. It is more common in far eastern countries and relatively rare in the United States and western European countries where at autopsy... Hepatocellular carcinoma (HCC) is one of the most frequent malignancies in the world. It is more common in far eastern countries and relatively rare in the United States and western European countries where at autopsy it accounts for only 1-2% of malignant rumors, The disease is usually manifested in the the 6^th and 7^th decade of life. HCC is one of the highly malignant neoplasms, Extrahepatic metastases are seen in 64% of patients with HCC. The lungs, regional lymph nodes, kidney, bone marrow and adrenals are common sites of HCC metastasis^[1-3], But, metastasis to brain and skull is extremely rare. Table I shows some of the reported cases of HCC with brain metastasis. These case reports reaffirms the complex and multidisciplinary care of these patients^[4-5]. 展开更多
关键词 brain neoplasms Carcinoma Hepatocellular Humans Liver neoplasms MALE Middle Aged Tomography X-ray Computed
下载PDF
A Phase Ⅰ trial of dose escalation of topotecan combined with whole brain radiotherapy for brain metastasis in lung cancer 被引量:1
9
作者 Xiaohui Ge Wenyan Zhao +5 位作者 Xiaocang Ren Yongqiang Wang Zhigang Li Yanqi Li Yuee Liu Qiang Lin 《The Chinese-German Journal of Clinical Oncology》 CAS 2012年第8期449-451,共3页
Objective The aim of this study was to define the maximum-tolerated dose (MTD) and observe the toxicity of escalating topotecan combined whole brain radiotherapy for brain metastasis in lung cancer.
关键词 brain metastasis neoplasm/lung cancer TOPOTECAN raDIOTHEraPY CHEMOTHEraPY maximum tolerated dose
下载PDF
BRAVF-V600E突变型实性多形性黄色星形细胞瘤的MRI分析 被引量:2
10
作者 钟文静 黄聪 +1 位作者 王芳 王宇军 《中国临床医学影像杂志》 CAS CSCD 2023年第6期390-393,共4页
目的:探讨BRAVF-V600E突变型实性多形性黄色星形细胞瘤(Pleomorphic xanthoastrocytoma,PXA)的MRI表现。方法:回顾性分析8例经病理证实为PXA、分子检测为BRAVF-600突变及MRI表现为实性肿块患者的临床及MRI资料,总结其MRI表现。结果:8例... 目的:探讨BRAVF-V600E突变型实性多形性黄色星形细胞瘤(Pleomorphic xanthoastrocytoma,PXA)的MRI表现。方法:回顾性分析8例经病理证实为PXA、分子检测为BRAVF-600突变及MRI表现为实性肿块患者的临床及MRI资料,总结其MRI表现。结果:8例均为女性患者,平均年龄(41±14.2)岁。8例均为幕上单发病灶,额叶4例,左侧顶叶2例,左侧枕叶1例,右侧枕叶1例,呈类圆形、椭圆形或分叶状实性肿块,2例病灶以宽基底与大脑镰相连,5例病灶边缘见小囊变。瘤体T_(1)WI呈等/低信号,T_(2)WI及T_(2)FLAIR以稍高/高信号为主,DWI呈高/稍高信号,ADC图呈稍低信号;增强扫描1例局部斑片状强化,余7例呈明显均匀或不均匀强化,其中6例强化瘤体白质侧部分边界模糊,边缘见条状或尖角样明显或磨玻璃样强化区;5例累及邻近脑膜;7例瘤周重度水肿。3例1 H-MRS检查示病灶NAA峰降低,Cho峰升高,2例出现Lac峰。结论:BRAVF-V600E突变型实性PXA的MRI表现有一定特征性,中年患者脑皮层或皮层下实性肿块伴瘤周重度水肿,增强明显强化,注意识别强化瘤体周围的磨玻璃样强化区有助于其术前诊断及鉴别诊断。 展开更多
关键词 脑肿瘤 星形细胞瘤 磁共振成像
下载PDF
Different oncological features of colorectal cancer codon-specific KRAS mutations:Not codon 13 but codon 12 have prognostic value 被引量:3
11
作者 Hong-Min Ahn Duck-Woo Kim +6 位作者 Tae Gyun Lee Hye-Rim Shin In Jun Yang Jeehye Lee Jung Wook Suh Heung-Kwon Oh Sung-Bum Kang 《World Journal of Gastroenterology》 SCIE CAS 2023年第32期4883-4899,共17页
BACKGROUND Approximately 40%of colorectal cancer(CRC)cases are linked to Kirsten rat sarcoma viral oncogene homolog(KRAS)mutations.KRAS mutations are associated with poor CRC prognosis,especially KRAS codon 12 mutatio... BACKGROUND Approximately 40%of colorectal cancer(CRC)cases are linked to Kirsten rat sarcoma viral oncogene homolog(KRAS)mutations.KRAS mutations are associated with poor CRC prognosis,especially KRAS codon 12 mutation,which is associated with metastasis and poorer survival.However,the clinicopathological characteristics and prognosis of KRAS codon 13 mutation in CRC remain unclear.AIM To evaluate the clinicopathological characteristics and prognostic value of codonspecific KRAS mutations,especially in codon 13.METHODS This retrospective,single-center,observational cohort study included patients who underwent surgery for stage I-III CRC between January 2009 and December 2019.Patients with KRAS mutation status confirmed by molecular pathology reports were included.The relationships between clinicopathological characteristics and individual codon-specific KRAS mutations were analyzed.Survival data were analyzed to identify codon-specific KRAS mutations as recurrence-related factors using the Cox proportional hazards regression model.RESULTS Among the 2203 patients,the incidence of KRAS codons 12,13,and 61 mutations was 27.7%,9.1%,and 1.3%,respectively.Both KARS codons 12 and 13 mutations showed a tendency to be associated with clinical characteristics,but only codon 12 was associated with pathological features,such as stage of primary tumor(T stage),lymph node involvement(N stage),vascular invasion,perineural invasion,tumor size,and microsatellite instability.KRAS codon 13 mutation showed no associations(77.2%vs 85.3%,P=0.159),whereas codon 12 was associated with a lower 5-year recurrence-free survival rate(78.9%vs 75.5%,P=0.025).In multivariable analysis,along with T and N stages and vascular and perineural invasion,only codon 12(hazard ratio:1.399;95%confidence interval:1.034-1.894;P=0.030)among KRAS mutations was an independent risk factor for recurrence.CONCLUSION This study provides evidence that KRAS codon 13 mutation is less likely to serve as a prognostic biomarker than codon 12 mutation for CRC in a large-scale cohort. 展开更多
关键词 Genes ras CODON Colonic neoplasms Rectal neoplasms
下载PDF
Diffusion tensor imaging and proton magnetic resonance spectroscopy in brain tumor Correlation between structure and metabolism
12
作者 Zhigang Min Chen Niu +2 位作者 Netra Rana Huanmei Ji Ming Zhang 《Neural Regeneration Research》 SCIE CAS CSCD 2013年第10期930-937,共8页
Proton magnetic resonance spectroscopy and diffusion tensor imaging are non-invasive techniques used to detect metabolites and water diffusion in vivo. Previous studies have confirmed a positive correlation of individ... Proton magnetic resonance spectroscopy and diffusion tensor imaging are non-invasive techniques used to detect metabolites and water diffusion in vivo. Previous studies have confirmed a positive correlation of individual fractional anisotropy values with N-acetylaspartate/creatine and N-acetylaspartate/choline ratios in tumors, edema, and normal white matter. This study divided the brain parenchyma into tumor, pedtumoral edema, and normal-appearing white matter according to MRI data, and analyzed the correlation of metabolites with water molecular diffusion. Results demonstrated that in normal-appearing white matter, N-acetylaspartate/creatine ratios were positively correlated with fractional anisotropy values, negatively correlated with radial diffusivities, and positively correlated with maximum eigenvalues. Maximum eigenvalues and radial diffusivities in peritumoral edema showed a negative correlation with choline, N-acetylaspartate, and creatine. Radial diffusivities in tumor demonstrated a negative correlation with choline. These data suggest that the relationship between metabolism and structure is markedly changed from normal white matter to peritumoral edema and tumor. Neural metabolism in the peritumoral edema area decreased with expanding extracellular space. The normal relationship of neural function and microstructure disappeared in the tumor region. 展开更多
关键词 neural regeneration NEUROIMAGING brain neoplasms magnetic resonance spectroscopy diffusiontensor imaging METABOLISM diffusion anisotropy EDEMA nerve fiber extracellular space correlation analysis grants-supported paper NEUROREGENEraTION
下载PDF
Microsurgical Treatment of Occupying-space Lesions of Brainstem
13
作者 Yu-guangLiu YuLi +3 位作者 MengLiu Wan-dongSu Xin-gangLi Shu-ganZhu 《Chinese Medical Sciences Journal》 CAS CSCD 2004年第2期96-96,共1页
关键词 ADOLESCENT Adult ASTROCYTOMA brain Diseases brain neoplasms brain Stem Female Follow-Up Studies HEMATOMA Humans Magnetic Resonance Imaging Male MICROSURGERY Middle Aged Tomography X-ray Computed
下载PDF
Parent’s Perceived Provision of Information Regarding Diagnosis to Children with Brain Tumors
14
作者 Iori Sato Akiko Higuchi +10 位作者 Takaaki Yanagisawa Akitake Mukasa Kohmei Ida Yutaka Sawamura Kazuhiko Sugiyama Nobuhito Saito Toshihiro Kumabe Mizuhiko Terasaki Ryo Nishikawa Yasushi Ishida Kiyoko Kamibeppu 《Open Journal of Nursing》 2015年第5期451-464,共14页
Background: The aim of this study was to clarify the degree of information provision to children with brain tumors, factors influencing this provision, and the relationship between this provision and psychosocial cons... Background: The aim of this study was to clarify the degree of information provision to children with brain tumors, factors influencing this provision, and the relationship between this provision and psychosocial consequences. Methods: A total of 157 parents completed a questionnaire on the degree of information provision to their children and sociodemographic and medical characteristics. Parents and their children completed subscales of the Pediatric Quality of Life Inventory (PedsQL) Cancer Module. Relevant factors were investigated using ordinal logistic regression analysis and compared with PedsQL scores by degree of information provision with adjustment for age. Results: The majority of children aged 2 - 4 years received a low level of information only in regard to medical procedure and preparation. The majority of children aged 5 - 11 years were provided information regarding disease symptoms and treatment, but not actual diagnosis. Approximately half of children aged 12 - 18 years were provided detailed information including their actual diagnosis. Older children generally received more information regarding their disease (odds ratio [OR] = 1.3 per 1 year old, P < 0.001), while children with intellectual disability received less (OR = 0.2, P = 0.006). The provision of information did not worsen scores for Procedural Anxiety, Treatment Anxiety, Worry, or Communication. Conclusions: To our knowledge, this is the first report on the degree of information provision to children with brain tumors. Parents of children with brain tumors in Japan provide information dependent on age and intellectual level. The disclosure of information to children regarding their disease might affect their trust of medical and health care professionals. 展开更多
关键词 ADOLESCENT brain neoplasms Child Quality of Life TRUTH DISCLOSURE
下载PDF
EXPRESSION OF IL-13Ra2 GENE IN HUMAN BRAIN TUMORS
15
作者 吴安华 铁欣昕 +1 位作者 王运杰 杨国瑞 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2005年第3期157-160,共4页
Objective: To investigate the expression of IL-13Ra2 gene in brain tumors. Methods: Seventy-nine human brain tumors were obtained from the department of Neurosurgery of China Medical University. Human IL-13Ra2 expre... Objective: To investigate the expression of IL-13Ra2 gene in brain tumors. Methods: Seventy-nine human brain tumors were obtained from the department of Neurosurgery of China Medical University. Human IL-13Ra2 expression was evaluated by reverse transcriptase polymerase chain reaction and immunohistochemical analysis. Results: IL-13Ra2 gene was highly expressed in glioblastoma, medulloblastoma, malignant meningioma and benign meningioma. Conclusion: Human IL-13Ra2 gene is expressed in brain tumors in addition to gliomas, and our result indicates that the IL-13Ra2 gene promoter based gene therapy method can be used to treat brain tumors in addition to gliomas. Further studies involving larger numbers of samples are necessary to fully understand the expression profile of IL-13Ra2 gene in the brain tumors. 展开更多
关键词 IL-13ra2 GLIOMA brain tumor
下载PDF
Experimental study on angiogenesis in rabbit VX_2 brain tumor using perfusion CT
16
作者 Liqing Kang Yunting Zhang Shimei Sun 《The Chinese-German Journal of Clinical Oncology》 CAS 2006年第6期431-435,共5页
Objective: To study the perfusion CT features of rabbit VX2 brain tumor with correlation to MVD and VEGF, and to validate perfusion CT for reflection of tumor angiogenesis. Methods: Rabbit VX2 brain tumor model was ... Objective: To study the perfusion CT features of rabbit VX2 brain tumor with correlation to MVD and VEGF, and to validate perfusion CT for reflection of tumor angiogenesis. Methods: Rabbit VX2 brain tumor model was established by injection of 100 μL viable tumor cells (10qmL) through a 2 mm-hole 5 mm to the right of the sagittal suture and 5 mm posterior to the coronal suture bored by dental drill. MRI was performed every 2 days after seven days of implantation to evaluate the growth of the tumor. Twenty New Zealand White rabbits with tumor size over 3 mm in diameter were randomly divided into 2 groups according to the tumor growth time with those less than 3 weeks as group 1 and those more than 3 weeks as group 2, and perfusion CT were performed accordingly. CT measurements of BV, BF and PS from tumor, peritumor and contralateral normal tissue regions were obtained. After that the animals were sacrificed and 2% Evans blue (2 mL/kg) was given intravenously in 16 of these animals 1 h prior to sacrifice to detect breakdown of the blood brain barrier. VEGF and MVD were evaluated in immunohistochemical examination of the specimens. Results: Tumor had significantly higher BV, BF and PS (P=0.000) than peritumor and normal tissue region. Tumor BV, BF and MVD in group 2 were significantly higher than that in group 1 (P〈0.01). Significant linear correlation was found between MVD and BV (t=-0.915, P=-0.000), MVD and BF (t=0.901, P=-0.000), and MVD and PS (t=-0.459, P=0.042). We also found a rank correlation between PS and blue stain of tumor (rs=0.861, P=0.000). Conclusion: Perfusion CT can distinguish tumor from peritumor and normal tissue clearly, reflect tumor angiogenesis accurately, and provide useful information for the evaluation of brain tumor. 展开更多
关键词 brain neoplasms angiogenesis factor PERFUSION tomography X-ray computed
下载PDF
Langerhans cell histiocytosis presenting as an isolated brain tumour:A case report
17
作者 Han-Xiang Liang Yue-Long Yang +3 位作者 Qing Zhang Zhi Xie En-Tao Liu Shu-Xia Wang 《World Journal of Clinical Cases》 SCIE 2022年第4期1423-1431,共9页
Langerhans cell histiocytosis(LCH)is a rare proliferative histiocyte disorder.It can affect any organ or system,especially the bone,skin,lung,and central nervous system(CNS).In the CNS,the hypothalamic-pituitary is pr... Langerhans cell histiocytosis(LCH)is a rare proliferative histiocyte disorder.It can affect any organ or system,especially the bone,skin,lung,and central nervous system(CNS).In the CNS,the hypothalamic-pituitary is predominantly affected,whereas the brain parenchyma is rarely affected.LCH occurring in the brain parenchyma can be easily confused with glioblastoma or brain metastases.Thus,multimodal imaging is useful for the differential diagnosis of these intracerebral lesions and detection of lesions in the other organs.CASE SUMMARY A 47-year-old man presented with a headache for one week and sudden syncope.Brain computed tomography(CT)and magnetic resonance imaging showed an irregularly shaped nodule with heterogeneous enhancement.On^(18)F-fluorodeoxyglucose(^(18)F-FDG)positron emission tomography/CT,a nodule with^(18)F-FDG uptake and multiple cysts in the upper lobes of both lungs were noted,which was also confirmed by high-resolution CT.Thus,the patient underwent surgical resection of the brain lesion for further examination.Postoperative pathology confirmed LCH.The patient received chemotherapy after surgery.No recurrence was observed in the brain at the 12-mo follow-up.CONCLUSION Multimodal imaging is useful for evaluating the systemic condition of LCH,developing treatment plans,and designing post-treatment strategies. 展开更多
关键词 Langerhans cell histiocytosis brain neoplasms LUNG Computed tomography Magnetic resonance imaging Positron emission tomography/computed tomography Case report
下载PDF
^(131)I treatment for brain metastases from differentiated thyroid carcinoma
18
作者 YUYong-Li LUHan-Kui ZHURei-Sen MAJi-Xiao 《Nuclear Science and Techniques》 SCIE CAS CSCD 2004年第4期223-226,共4页
To assess the clinical value of treatment with 131I for brain metastases from differentiated thyroid cancer (DTC), we have observed 8 cases of brain metastases from DTC who received follow-up after 131I therapy (2male... To assess the clinical value of treatment with 131I for brain metastases from differentiated thyroid cancer (DTC), we have observed 8 cases of brain metastases from DTC who received follow-up after 131I therapy (2male, 6 female, aged 12~65 years). The results of 131I therapy were evaluated with clinical presentation, imaging scan and survival analysis. The main results are as follows. (1) All cases had been survival for 2~35 years in follow-up. (2)A space-occupying lesion in right cerebellum was reduced after taking 20.65 GBq and disappeared after 23.61 GBq,demonstrated by computed tomography. (3) The sequences and doses of 131I therapy were clearly decreased for the cases with total thyroidectomy in comparison with those with semithyroidectomy (p<0.01). (4) The brain metastases with lung and/or bone metastasis from DTC were 75% (6/8) and it was difficult to cure these metastases at the same time. It is concluded that the postoperative treatment of 131I for brain metastases from DTC after undergoing thyroidectomy may improve clinical symptoms and life quality, reduce lesions, and prolong survival. 展开更多
关键词 脑瘤 射线疗法 甲状腺瘤 碘-131 放射医学
下载PDF
Phosphorylated S6K1 and 4E-BP1 play different roles in constitutively active Rheb-mediated retinal ganglion cell survival and axon regeneration after optic nerve injury
19
作者 Jikuan Jiang Lusi Zhang +5 位作者 Jingling Zou Jingyuan Liu Jia Yang Qian Jiang Peiyun Duan Bing Jiang 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第11期2526-2534,共9页
Ras homolog enriched in brain(Rheb) is a small GTPase that activates mammalian target of rapamycin complex 1(mTORC1).Previous studies have shown that constitutively active Rheb can enhance the regeneration of sensory ... Ras homolog enriched in brain(Rheb) is a small GTPase that activates mammalian target of rapamycin complex 1(mTORC1).Previous studies have shown that constitutively active Rheb can enhance the regeneration of sensory axons after spinal cord injury by activating downstream effectors of mTOR.S6K1 and4E-BP1 are important downstream effectors of mTORC1.In this study,we investigated the role of Rheb/mTOR and its downstream effectors S6K1 and 4E-BP1in the protection of retinal ganglion cells.We transfected an optic nerve crush mouse model with adeno-associated viral 2-mediated constitutively active Rheb and observed the effects on retinal ganglion cell survival and axon regeneration.We found that overexpression of constitutively active Rheb promoted survival of retinal ganglion cells in the acute(14 days) and chronic(21 and 42 days) stages of injury.We also found that either co-expression of the dominant-negative S6K1mutant or the constitutively active 4E-BP1 mutant together with constitutively active Rheb markedly inhibited axon regeneration of retinal ganglion cells.This suggests that mTORC1-mediated S6K1 activation and 4E-BP1 inhibition were necessary components for constitutively active Rheb-induced axon regeneration.However,only S6K1 activation,but not 4E-BP1 knockdown,induced axon regeneration when applied alone.Furthermore,S6K1 activation promoted the survival of retinal ganglion cells at 14 days post-injury,whereas 4E-BP1 knockdown unexpectedly slightly decreased the survival of retinal ganglion cells at 14 days postinjury.Ove rexpression of constitutively active 4E-BP1 increased the survival of retinal ganglion cells at 14 days post-injury.Likewise,co-expressing constitutively active Rheb and constitutively active 4E-BP1 markedly increased the survival of retinal ganglion cells compared with overexpression of constitutively active Rheb alone at 14 days post-injury.These findings indicate that functional 4E-BP1 and S6K1 are neuroprotective and that 4E-BP1 may exert protective effects through a pathway at least partially independent of Rhe b/mTOR.Together,our results show that constitutively active Rheb promotes the survival of retinal ganglion cells and axon regeneration through modulating S6K1 and 4E-BP1 activity.Phosphorylated S6K1 and 4E-BP1 promote axon regeneration but play an antagonistic role in the survival of retinal ganglion cells. 展开更多
关键词 axon regeneration central nervous system gene therapy mRNA translation NEURODEGENEraTION NEUROPROTECTION optic nerve crush ras homolog enriched in the brain retina translation initiation
下载PDF
基于脑MRI的机器学习预测非小细胞肺癌T790M突变
20
作者 崔婀娜 杨春娜 +3 位作者 王晓煜 沙宪政 赵鹏 孙艺瑶 《中国临床医学影像杂志》 CAS CSCD 北大核心 2024年第3期153-159,共7页
目的:本研究基于脑部T_(1)C和T_(2)W MRI建立人工智能模型,预测肺癌脑转移患者在靶向治疗中的耐药性T790M突变。方法:本研究收集80例肺癌脑转移患者(2017年6月—2019年12月)的T_(1)C和T_(2)W MRI影像和临床数据进行回顾性分析(患者按照2... 目的:本研究基于脑部T_(1)C和T_(2)W MRI建立人工智能模型,预测肺癌脑转移患者在靶向治疗中的耐药性T790M突变。方法:本研究收集80例肺癌脑转移患者(2017年6月—2019年12月)的T_(1)C和T_(2)W MRI影像和临床数据进行回顾性分析(患者按照2∶1的比例分成训练集和测试集)。采用无监督k-means算法将肿瘤区域划分为高亮度区域和低亮度区域,提取不同区域的影像组学图像特征构建模型,评估每个模型的诊断效果。绘制受试者工作特征(Receiver operating characteristic,ROC)曲线,计算ROC曲线下面积(Area under curve,AUC)、特异性和敏感性作为模型评价指标,分析模型的潜在临床应用价值。结果:对T_(1)C和T_(2)W MRI和临床特征融合的统计计算表明,本研究建立的模型对T790M突变具有良好的预测能力,在训练集和测试集上的AUC分别为0.899和0.818。结论:本研究建立的计算机模型可以有效预测肺癌脑转移患者T790M突变,具有潜在的临床辅助诊断价值。 展开更多
关键词 非小细胞肺 脑肿瘤 肿瘤转移 磁共振成像
下载PDF
上一页 1 2 131 下一页 到第
使用帮助 返回顶部